These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37860180)

  • 61. Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Shen P; Yang J; Wei W; Li Y; Li D; Zeng H; Wang J
    BJU Int; 2012 Sep; 110(6 Pt B):E209-15. PubMed ID: 22288379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer.
    Liu P; Chen S; Gao X; Liang H; Sun D; Shi B; Zhang Q; Guo H
    Front Immunol; 2022; 13():1032907. PubMed ID: 36225922
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.
    Lamm D; Brausi M; O'Donnell MA; Witjes JA
    Urol Oncol; 2014 Jan; 32(1):35.e21-30. PubMed ID: 23628309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. p53 Status correlates with the risk of recurrence in non-muscle invasive bladder cancers treated with Bacillus Calmette-Guérin: a meta-analysis.
    Zhou X; Zhang G; Tian Y
    PLoS One; 2015; 10(3):e0119476. PubMed ID: 25742650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis.
    Lu JL; Xia QD; Liu CQ; Sun JX; Yang YY; Hu HL; Wang SG
    Transl Cancer Res; 2021 Jun; 10(6):2849-2858. PubMed ID: 35116595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis.
    Del Giudice F; Busetto GM; Gross MS; Maggi M; Sciarra A; Salciccia S; Ferro M; Sperduti I; Flammia S; Canale V; Chung BI; Conti SL; Eisenberg ML; Skinner EC; De Berardinis E
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3073-3080. PubMed ID: 33675400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.
    Del Giudice F; Flammia RS; Chung BI; Moschini M; Pradere B; Mari A; Soria F; Albisinni S; Krajewski W; Szydełko T; Laukhtina E; D'Andrea D; Gallioli A; Mertens LS; Maggi M; Sciarra A; Salciccia S; Ferro M; Scornajenghi CM; Asero V; Cattarino S; De Angelis M; Cacciamani GE; Autorino R; Pandolfo SD; Falagario UG; D'Altilia N; Mancini V; Chirico M; Cinelli F; Bettocchi C; Cormio L; Carrieri G; De Berardinis E; Busetto GM; On Behalf Of European Association Of Urology Eau-Young Academic Urologists Yau Urothelial Cancer Working Party
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205635
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study].
    Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I
    Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
    Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E
    Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
    Busetto GM; Finati M; Chirico M; Cinelli F; D'Altilia N; Falagario UG; Sanguedolce F; Del Giudice F; De Berardinis E; Ferro M; Crocetto F; Porreca A; Di Gianfrancesco L; Calo' B; Mancini V; Bettocchi C; Carrieri G; Cormio L
    World J Urol; 2023 May; 41(5):1329-1335. PubMed ID: 36971825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
    Huang Z; Liu H; Wang Y; Zhang C; Xu T
    Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.
    Böhle A; Leyh H; Frei C; Kühn M; Tschada R; Pottek T; Wagner W; Knispel HH; von Pokrzywnitzki W; Zorlu F; Helsberg K; Lübben B; Soldatenkova V; Stoffregen C; Büttner H;
    Eur Urol; 2009 Sep; 56(3):495-503. PubMed ID: 19560257
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
    Tan WS; Prendergast A; Ackerman C; Yogeswaran Y; Cresswell J; Mariappan P; Phull J; Hunter-Campbell P; Lazarowicz H; Mishra V; Rane A; Davies M; Warburton H; Cooke P; Mostafid H; Wilby D; Mills R; Issa R; Kelly JD
    Eur Urol; 2023 Jun; 83(6):497-504. PubMed ID: 35999119
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    Lian F; Chen W; Liu Y; Shen L; Fan W; Cui W; Zhao Y; Li J; Wang Y
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1625-1633. PubMed ID: 30900154
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
    van Puffelen JH; Novakovic B; van Emst L; Kooper D; Zuiverloon TCM; Oldenhof UTH; Witjes JA; Galesloot TE; Vrieling A; Aben KKH; Kiemeney LALM; Oosterwijk E; Netea MG; Boormans JL; van der Heijden AG; Joosten LAB; Vermeulen SH
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36693678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer
    Rahman KMM; Foster BA; You Y
    Photochem Photobiol; 2023 Jul; ():. PubMed ID: 37469327
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer.
    Quhal F; Pradere B; Laukhtina E; Sari Motlagh R; Mostafaei H; Mori K; Schuettfort VM; Karakiewicz PI; Rouprêt M; Enikeev D; Rink M; Abufaraj M; Shariat SF
    World J Urol; 2021 Sep; 39(9):3345-3352. PubMed ID: 33496841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.